NCT07024095 Inspiratory Muscle Training After Vertebroplasty in Osteoporotic Fracture Patients
| NCT ID | NCT07024095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istinye University |
| Condition | Osteoporotic Vertebral Compression Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-04-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-07-01 with a primary completion date of 2026-04-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the long-term effects of inspiratory muscle training (IMT) on pulmonary function, functional capacity, and quality of life in individuals with osteoporotic vertebral compression fractures who have undergone percutaneous vertebroplasty. Participants aged 50 and older, diagnosed with osteoporosis and having undergone thoracic vertebroplasty within the past 3 months, will be randomly assigned to either an intervention group (IMT + standard rehabilitation) or a control group (standard rehabilitation only). The primary outcome measure is spirometry-based pulmonary function. Secondary outcome measures include inspiratory muscle strength, functional walking capacity (6-minute walk test), diaphragmatic structure and elasticity, and quality of life (SGRQ, NHP). This randomized controlled trial will be conducted at the Cardiopulmonary Rehabilitation Unit of Nuh Naci Yazgan University and aims to provide scientific evidence for integrating IMT into routine post-vertebroplasty rehabilitation protocols.
Eligibility Criteria
Inclusion Criteria: * Being 50 years of age or older at the time of the study, * Having a diagnosis of osteoporosis confirmed by a specialist physician, * Having undergone percutaneous vertebroplasty surgery due to an osteoporotic vertebral compression fracture in the thoracic region within the past 3 months, * Being cooperative with the questionnaires and assessment methods to be used in the study, * Being able to read and voluntarily agree to participate in the study by signing the informed consent form. Exclusion Criteria: * Having a history of diagnosed unstable cardiac disease, * Having a diagnosed pulmonary or neurological disorder, * Having experienced an acute infection within the past 15 days, * Being unable to participate in exercise interventions due to mental or cognitive impairment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07024095 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Osteoporotic Vertebral Compression Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07024095 currently recruiting?
Yes, NCT07024095 is actively recruiting participants. Contact the research team at oguzhanyilmaz68@gmail.com for enrollment information.
Where is the NCT07024095 trial being conducted?
This trial is being conducted at Kayseri, Turkey (Türkiye).
Who is sponsoring the NCT07024095 clinical trial?
NCT07024095 is sponsored by Istinye University. The trial plans to enroll 24 participants.